Schonfeld Strategic Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Schonfeld Strategic Advisors's AMGN Position: Q1 2026 in Review
Schonfeld Strategic Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 36,625 shares — an estimated $13.1M sold.
Schonfeld Strategic Advisors first reported a position in AMGN in Q3 2016 and held it in 26 quarters. The position peaked at $32.1M in Q2 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Schonfeld Strategic Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 36,625 Amgen shares in Q1 2026, an estimated $13.1M.
- Schonfeld Strategic Advisors first reported a position in Amgen in Q3 2016 and held it in 26 quarters.
- Schonfeld Strategic Advisors's Amgen position peaked at $32.1M in Q2 2022.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.